Dr. Robert Ndege is a Clinician and a Research Scientist heading the Chronic Diseases Clinic of Ifakara within the Interventions and Clinical Trials Department at IHI. He has the experience of over 4 years in HIV/TB patient care and research. He holds a Medical Degree from Hubert Kairuki Memorial University and an MSc. in Infectious Diseases from London School of Hygiene and Tropical Medicine under the University of London.

Dr. Ndege’s research interests range from management of, and epidemiological studies of infectious diseases and non-communicable diseases; as well as use of the ultrasound as a point of care diagnostic tool. He has completed training in Abdominal and Emergency Sonography from the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), and has been appointed as lecturer and instructor in courses in point of care abdominal and emergency ultrasound.

Dr. Robert joined the Institute in June 2016 after completion of his internship at Bugando Medical Center. He was trained as a Medicine Doctor at Hubert Kairuki memorial University in Dar es Salaam, Tanzania and graduated in 2014.  He later on pursued a Msc in Infectious Diseases from London School of Hygiene and Tropical Medicine under the University of London which he successfully completed in the year 2020.

Dr. Robert began his career in research in 2016 as a research officer/clinician at IHI and since then he has participated in different clinical research activities in Tanzania with several publications in the field of HIV and TB.

He is also skilled in the creation and management of data capturing tools such as EpiData, EpiInfo, Microsoft Access. He holds a certificate in Database Management from the University of Dar es Salaam Computing Center.

Research Areas: His research interests include: epidemiology of infectious diseases such as tuberculosis, Schistosomiasis, Malaria and HIV/AIDS; epidemiology of non-communicable diseases.

Projects: Currently, Dr. Robert is involved in two IHI projects at IHI: The first project where he is a Co-Principal investigator is the Kilombero Ulanga antiretroviral Cohort (KIULARCO) where he heads the Chronic Disease Clinic of Ifakara (CDCI), involved in and supervising the in- and out-patient care of HIV positive patients, as well as TB co-infected patients attending the clinic.

The second project in which he is the Principal Investigator is a Randomized controlled two-center study ( one in rural and the other in urban Tanzania), which is aiming at the improvement in the diagnosis and management of Extrapulmonary tuberculosis through focused assessment by ultrasound a multicenter trial being conducted at the St. Francis Referral Hospital in Ifakara, Morogoro and the Mwananyamala Referral Hospital, Dar es Salaam.#